Overview

Optimized Heparin Regimen in Vascular Surgery

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Optimal anticoagulation defined as an Activated Clotting Time (ACT) of 300 to 350 seconds obtained by weight-adjusted doses of unfractionated heparin (UFH) will improve the hemostatic environment downstream from the vascular clamp, provide better blood flow in the distal bed following peripheral revascularization surgery. Objectives: This study is designed to assess the effects of an optimized regimen of UFH on the hemostatic environment downstream from the vascular clamp in major vascular surgery.
Phase:
N/A
Details
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Treatments:
Anesthetics
Calcium heparin
Heparin
Polystyrene sulfonic acid